The Antimicrobial Drugs Advisory Committee, which advises the U.S. Food and Drug Administration, meets at 9 a.m. ET on March 16 to discuss a new application for Pfizer’s Paxlovid pill for oral use. The pill treats mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID 19, including hospitalization or death.
FDA Advisers Meet to Discuss Pfizer’s COVID-19 Pill
By NTD Video
Live Chat
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.